Astrotech's TRACER 1000 Secures First TSA Sale, Expands Global Footprint

TL;DR

**ASTC's TRACER 1000 is finally gaining traction with TSA approval and initial sales, making it a speculative buy for those betting on a security tech upgrade cycle.**

AI Summary

Astrotech Corporation (ASTC) reported significant advancements in commercializing its Astrotech Mass Spectrometer Technology (AMS Technology) platform through its wholly-owned subsidiaries for the fiscal year ended June 30, 2025. The company's 1st Detect subsidiary achieved a major milestone with the TSA approval of its TRACER 1000 for the Air Cargo Security Technology List in June 2024, advancing to Stage II testing. In April 2025, Astrotech received and fulfilled a $429,000 purchase order for six TRACER 1000 explosive trace detectors from Intuitive Research and Technology, marking its first TSA-approved sale. The TRACER 1000 has been deployed in approximately 34 locations across 16 countries. Additionally, 1st Detect was awarded a research and development contract with the United States Department of Homeland Security (DHS) on January 14, 2025, for next-generation explosives trace detection. The company also launched the enhanced TRACER 1000 Narcotic Trace Detector (NTD) on March 10, 2025, and secured its first international sale and deployment in Vietnam on June 12, 2025. AgLAB, another subsidiary, continues field trials for its AgLAB 1000-D2 to optimize yields in hemp and cannabis distillation, targeting a global market exceeding $6 billion annually in the U.S. alone.

Why It Matters

Astrotech's recent TSA approval and first significant sale of the TRACER 1000 ETD for $429,000 signals a potential breakthrough in the competitive security detection market, dominated by less accurate IMS-based systems. This could lead to increased market share for ASTC, impacting investors positively through revenue growth and potentially higher stock valuation. For employees, it validates years of R&D and secures future opportunities in a critical sector. Customers, particularly airports and cargo facilities, stand to benefit from more accurate and efficient threat detection, reducing false alarms and operational disruptions. The broader market could see a shift towards more advanced mass spectrometry technology in security, raising the bar for competitors.

Risk Assessment

Risk Level: medium — The company is heavily reliant on the successful commercialization and adoption of its AMS Technology, particularly the TRACER 1000. While TSA approval for Stage II testing and the initial $429,000 purchase order are positive, significant revenue generation depends on widespread adoption and successful completion of further testing, including TSA checkpoint testing. The forward-looking statements also highlight risks such as product demand, market acceptance, and uncertainty in government funding, indicating that future success is not guaranteed despite recent progress.

Analyst Insight

Investors should monitor ASTC's progress in completing TSA Stage II field trials and checkpoint testing, as these are critical for broader market penetration. The initial $429,000 sale is a positive indicator, but sustained revenue growth and further government contracts will be key to validating the investment thesis. Consider a small position if you believe in the long-term adoption of superior security technology.

Key Numbers

• $429,000 — Purchase Order Value (Value of the first TSA-approved sale of six TRACER 1000 ETDs in April 2025)
• 34 — Deployment Locations (Number of locations where TRACER 1000 has been deployed as of June 30, 2025)
• 16 — Countries (Number of countries where TRACER 1000 has been deployed as of June 30, 2025)
• 2019 — ECAC Certification Year (Year TRACER 1000 received European Civil Aviation Conference certification)
• 2024 — TSA Approval Year (Year TRACER 1000 was approved by TSA for Air Cargo Security Technology List)
• $6 billion — U.S. Cannabis Wholesale Value (Annual wholesale value of the cannabis crop in U.S. states permitting adult-use and medical cannabis)
• 1,758,953 — Shares Outstanding (Number of common stock shares issued and outstanding as of September 24, 2025)
• $10,083,870 — Market Value of Non-Affiliate Equity (Aggregate market value of voting and non-voting common equity held by non-affiliates as of December 31, 2024)

Key Players & Entities

• Astrotech Corporation (company) — parent company commercializing AMS Technology
• 1st Detect Corporation (company) — subsidiary manufacturing explosive and narcotic trace detectors
• TRACER 1000 (product) — mass spectrometer-based explosive trace detector
• TSA (regulator) — U.S. Transportation Security Administration, approved TRACER 1000 for Air Cargo Security Technology List
• Intuitive Research and Technology (company) — TSA approved contractor that purchased TRACER 1000 ETDs
• AgLAB, Inc. (company) — subsidiary developing mass spectrometers for hemp and cannabis market
• DHS (regulator) — United States Department of Homeland Security, awarded R&D contract to 1st Detect
• ECAC (regulator) — European Civil Aviation Conference, certified TRACER 1000 in 2019

FAQ

Risk Factors

• TSA Approval and Certification Dependence [high — regulatory]: The company's success, particularly for its 1st Detect subsidiary, is heavily reliant on obtaining and maintaining approvals and certifications from regulatory bodies like the TSA and ECAC. The TRACER 1000 received TSA approval for the Air Cargo Security Technology List in June 2024 and ECAC certification in 2019. Delays or failures in obtaining these critical certifications could significantly hinder market penetration and sales.
• Competition in Trace Detection Market [medium — market]: The markets for explosive and narcotic trace detectors, as well as cannabis analysis, are competitive. While ASTC has secured TSA approval for its TRACER 1000 and is developing products for the cannabis market, it faces established players and emerging technologies. The company's ability to differentiate its AMS Technology and secure market share against competitors will be crucial.
• Manufacturing and Supply Chain Reliance [medium — operational]: The company relies on its subsidiaries, 1st Detect and AgLAB, for manufacturing and product development. Disruptions in their operations, supply chain issues, or inability to scale production to meet demand could impact the timely delivery of products like the TRACER 1000 and AgLAB 1000-D2.
• Dependence on Government Contracts and Purchase Orders [medium — financial]: A significant portion of revenue may depend on government contracts and purchase orders, such as the $429,000 order for TRACER 1000 units from Intuitive Research and Technology. The cyclical nature or cancellation of such contracts could lead to revenue volatility.
• Cannabis Market Volatility and Regulation [medium — market]: AgLAB's focus on the hemp and cannabis market, valued at over $6 billion annually in the U.S., exposes the company to the evolving regulatory landscape and market volatility within this sector. Changes in state or federal laws regarding cannabis could impact AgLAB's growth prospects.

Industry Context

Astrotech operates in the specialized markets of security screening technology and analytical instrumentation for niche industries like agriculture. The security sector is driven by evolving threats and regulatory mandates, requiring continuous innovation in detection capabilities. The agricultural analytics market, particularly for cannabis, is a rapidly growing segment influenced by changing regulations and demand for yield optimization and quality control.

Regulatory Implications

The company's primary regulatory hurdles involve obtaining and maintaining certifications from bodies like the TSA and ECAC for its security products. Compliance with evolving security standards and successful navigation of the approval processes are critical for market access and sales. The AgLAB subsidiary also faces regulatory considerations tied to the legal status and testing requirements of the cannabis industry.

What Investors Should Do

1. Monitor TSA and international security agency approvals.
2. Track sales pipeline and contract wins, especially from government entities.
3. Assess progress and market adoption of the AgLAB 1000-D2.
4. Evaluate competitive landscape and technological differentiation.

Key Dates

• 2019-01-01: ECAC Certification for TRACER 1000 — Provided initial European market access and validation for the TRACER 1000 explosive trace detector.
• 2024-06-01: TSA Approval for TRACER 1000 — TRACER 1000 was approved for the Air Cargo Security Technology List, a critical step for U.S. market penetration in air cargo security.
• 2025-01-14: DHS R&D Contract Awarded — Secured a contract for next-generation explosives trace detection, indicating continued government interest and potential for future product development and sales.
• 2025-03-10: Launch of TRACER 1000 Narcotic Trace Detector (NTD) — Expanded product offering into the narcotic detection market, broadening potential customer base and revenue streams.
• 2025-04-01: First TSA-Approved Sale of TRACER 1000 — Fulfilled a $429,000 purchase order for six TRACER 1000 ETDs, marking the first commercial sale post-TSA approval and validating the product's market readiness.
• 2025-06-12: First International NTD Sale and Deployment — Secured the first international sale of the TRACER 1000 NTD in Vietnam, demonstrating global market potential beyond the U.S. and Europe.

Glossary

AMS Technology

Astrotech Mass Spectrometer Technology, a proprietary platform for precise detection and identification of chemical compounds. (This is the core technology underpinning all of Astrotech's products, enabling their advanced detection capabilities.)

ETD

Explosive Trace Detector, a device used to detect the presence of explosive materials. (The TRACER 1000 is an ETD, and its TSA approval is a key driver for the company's security segment.)

NTD

Narcotic Trace Detector, a device used to detect the presence of illicit drugs. (The recent launch of the TRACER 1000 NTD expands the company's product applications and market reach.)

TSA

Transportation Security Administration, a U.S. government agency responsible for security in the nation's transportation systems. (TSA approval is critical for the adoption of ASTC's security products in U.S. airports and cargo facilities.)

ECAC

European Civil Aviation Conference, an intergovernmental organization that aims to promote the harmonization of civil aviation policies and procedures. (ECAC certification was an early validation for the TRACER 1000, enabling its deployment in European aviation security.)

DHS

Department of Homeland Security, a U.S. federal agency responsible for national security. (A contract with the DHS for R&D signifies government trust and potential future business opportunities.)

Mass Spectrometry (MS)

An analytical technique that measures the mass-to-charge ratio of ions, used to determine the elemental composition of a sample, the masses of its components, and the structure of molecules. (This is the fundamental technology ASTC leverages for its detection devices.)

Gas Chromatography (GC)

A laboratory technique for separating and analyzing compounds that can be vaporized without decomposition. (Combined with MS, GC enhances the precision and capability of ASTC's detection instruments.)

Year-Over-Year Comparison

While specific comparative financial data from the prior year's 10-K is not detailed in this excerpt, the narrative indicates significant progress in commercialization. Key developments include achieving TSA approval for the TRACER 1000 in 2024 and securing the first TSA-approved sale in April 2025, suggesting a transition from development to revenue generation. The launch of the NTD and the ongoing AgLAB field trials point to expanded product lines and market reach compared to previous periods.

Key Financial Figures

• $0.001 — mon Stock ASTC on which registered $0.001 per share The Nasdaq Capital Market
• $6 — e Nasdaq Capital Market on such date of $6.72, was approximately $ 10,083,870 . Th
• $429,000 — s. In April 2025, Astrotech received a $429,000 purchase order for TRACER 1000 explosiv
• $6 billion — adult-use and medical cannabis exceeds $6 billion annually. We believe growth in the U.S.

Filing Documents

• astc20250630_10k.htm (10-K) — 1727KB
• ex_831006.htm (EX-4.1) — 61KB
• ex_863959.htm (EX-10.6) — 8KB
• ex_863960.htm (EX-10.7) — 10KB
• ex_863961.htm (EX-10.8) — 8KB
• ex_863962.htm (EX-10.9) — 27KB
• ex_831011.htm (EX-21.1) — 6KB
• ex_831013.htm (EX-23.1) — 3KB
• ex_831014.htm (EX-31.1) — 13KB
• ex_831015.htm (EX-31.2) — 13KB
• ex_831016.htm (EX-32.1) — 6KB
• ex_831017.htm (EX-32.2) — 6KB
• logo.jpg (GRAPHIC) — 10KB
• 0001437749-25-029909.txt ( ) — 8285KB
• astc-20250630.xsd (EX-101.SCH) — 68KB
• astc-20250630_cal.xml (EX-101.CAL) — 57KB
• astc-20250630_def.xml (EX-101.DEF) — 414KB
• astc-20250630_lab.xml (EX-101.LAB) — 425KB
• astc-20250630_pre.xml (EX-101.PRE) — 464KB
• astc20250630_10k_htm.xml (XML) — 1330KB

Business

Item 1. Business 6

Risk Factors

Item 1A. Risk Factors 6

Unresolved Staff Comments

Item 1B. Unresolved Staff Comments 49

Cybersecurity

Item 1C. Cybersecurity 49

Properties

Item 2. Properties 50

Legal Proceedings

Item 3. Legal Proceedings 51

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 51 PART II 51

Market for Registrant ' s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Item 5. Market for Registrant ' s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 51

Reserved

Item 6. Reserved 51

Management ' s Discussion and Analysis of Financial Condition and Results of Operations

Item 7. Management ' s Discussion and Analysis of Financial Condition and Results of Operations 51

Quantitative and Qualitative Disclosures About Market Risk

Item 7A. Quantitative and Qualitative Disclosures About Market Risk 59

Financial Statements and Supplementary Data

Item 8. Financial Statements and Supplementary Data 60

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 86

Controls and Procedures

Item 9A. Controls and Procedures 86

Other Information

Item 9B. Other Information 87 PART III 87

Directors, Executive Officers and Corporate Governance

Item 10. Directors, Executive Officers and Corporate Governance 87

Executive Compensation

Item 11. Executive Compensation 87

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 87

Certain Relationships and Related Transactions, and Director Independence

Item 13. Certain Relationships and Related Transactions, and Director Independence 87

Principal Accounting Fees and Services

Item 14. Principal Accounting Fees and Services 87 PART IV 88

Exhibits, Financial Statement Schedules

Item 15. Exhibits, Financial Statement Schedules 88

Form 10-K Summary

Item 16. Form 10-K Summary 91

SIGNATURES

SIGNATURES 92 3 Table of Contents

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This Form 10-K contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (the "Exchange Act"). All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws. Forward-looking statements may include the words "may," "will," "plans," "believes," "estimates," "expects," "intends" and other similar expressions. Such statements are subject to risks and uncertainties that could cause our actual results to differ materially from those projected in the statements. Such risks and uncertainties include, but are not limited to: The adverse expectations regarding the global economy, inflation, the potential for recession and geopolitical tensions and any resulting sanctions, or wars; The effect of economic and political conditions in the United States or other nations that could impact our ability to sell our products and services or gain customers; Product demand and market acceptance risks, including our ability to develop and sell products and services to be used by governmental or commercial customers; The impact of trade barriers imposed by the U.S. government, such as import/export duties and restrictions, tariffs and quotas, and potential corresponding actions by other countries in which we conduct our business; Technological difficulties and potential legal claims arising from any technological difficulties; The risks related to the availability of, and cost inflation in, supply chain inputs, including labor, raw materials, commodities, packaging, and transportation; Uncertainty in government funding and support for key programs, grant opportunities, or procurements; The impact of competition on our ability to win new contracts; Our ability to meet technological development milestones and overcome development challenges; and Our ability to successfully iden

Business

Item 1. Business Our Company The terms "Astrotech", "the Company", "we", "us", or "our" refer to Astrotech Corporation (Nasdaq: ASTC), a Delaware corporation organized in 1984. Our use of "products" and "devices" refer to the TRACER 1000, BreathTest-1000, AGLAB 1000, and Pro-Control 1000 along with related accessories and consumables. We are commercializing the Astrotech Mass Spectrometer Technology platform ("AMS Technology") through application specific, wholly owned subsidiaries. Our mission encompasses the advancement of both mass spectrometry and gas chromatography, two powerful analytical techniques that together enable precise detection and identification of chemical compounds across a wide range of high-demand environments. We aim toexpand access to mass spectrometry by simplifying the complexity of operating these devices within real-time testing environments such as airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, law enforcement centers, and industrial locations. We are introducing our new line of products that are ultra-portable, on-site, rugged environmental testing instruments, featuring our proprietary ATi Mass Spectrometer Technology ("MS") and ATi Gas Chromatography Column ("GC") to achieve our mission through simplifying the user interface, ruggedizing the critical components to endure MS/GC field work, and enabling multiple configurations for sample intake options. The Astrotech Mass Spectrometer Technology and ATi Gas Chromatograph Column (GC) platforms achieveour mission through simplifying the user interface, automating the complicated calibration process, ruggedizing the critical components to endure MS/GC field work, and enabling multiple configurations for sample intake options. Since the TRACER 1000 was certified by the European Civil Aviation Conference ("ECAC") in 2019, our customers have deployed our devices in approximately 34 locations 16 countries throughout United Sta

View Full Filing

View this 10-K filing on SEC EDGAR